To evaluate the therapeutic potential of targeting FBL in vivo, we generated lentiviruses carrying shRNAs against FBL or scrambled shRNA and delivered them to HCC PDXs to achieve FBL knockdown. Here, FBL is linked to hepatocellular carcinoma.